CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
There will be no interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06764277
NCT06764277N/ACompleted

Mechanisms and Phenotypes of Hypertension in Patients in Chronic Hemodialysis

Bernardo Rodríguez Iturbe·observational·Posted Jan 8, 2025·Updated Feb 3, 2026

In Brief

An observational study evaluating There will be no intervention for Arterial Hypertension and Hemodialysis. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The goal of this study is to evaluate interdialytic blood pressure changes of the patients in chronic hemodialysis. The main question to be answered is: What is the relative importance of weight gain, the renin angiotensin system, the sympathetic nervous system and inflammatory immune reactivity in the interdialytic hypertension of patients in chronic hemodialysis, The participants will have hemodynamic evaluation (cardiac output and peripheral vascular resistance) at the end of dialysis, ambulatory monitoring of blood pressure in the interdialytic period. Serum samples will be collected at the end of dialysis and before the start of the next dialysis, 2-3 days later.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesMexico
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJan 8, 2025
Enrollment StartAug 14, 2023
Primary CompletionDec 20, 2024
Study CompletionJun 6, 2025
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 1.5 years ago

Interventions

There will be no interventionother

There will be no intervention. This is an observational studies and 3 groups will be organized depending on the level of ABP in the interdialytic period